Cubist Systematic Strategies Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$62M |
| 2 |
Amazon
AMZN
|
+$53.3M |
| 3 |
CVS Health
CVS
|
+$40.3M |
| 4 |
PayPal
PYPL
|
+$34.8M |
| 5 |
McDonald's
MCD
|
+$34.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$56.8M |
| 2 |
EXE
Expand Energy Corp
EXE
|
+$43.4M |
| 3 |
Charter Communications
CHTR
|
+$42.4M |
| 4 |
Comcast
CMCSA
|
+$40.3M |
| 5 |
Mastercard
MA
|
+$37.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.54% |
| 2 | Technology | 11.9% |
| 3 | Consumer Discretionary | 9.77% |
| 4 | Healthcare | 8.91% |
| 5 | Industrials | 8.21% |
Similar funds
Cubist Systematic Strategies's Q4 2022 Portfolio in Review
As of Q4 2022, Cubist Systematic Strategies held 5,006 positions worth $17.1B, down 3.6% from $17.8B the previous quarter. Its ten largest holdings account for 3.1% of the portfolio.
Cubist Systematic Strategies withdrew a net $1.62B in Q4 2022, closing 822 positions and reducing 1,808 holdings. Its most notable exit was Edison International, an estimated $25.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Cubist Systematic Strategies opened a new position in Bristol-Myers Squibb worth $30.8M.
- Cubist Systematic Strategies's largest Q4 2022 buy was Bristol-Myers Squibb: 428,476 shares worth $30.8M.
- Cubist Systematic Strategies added most to Apple in Q4 2022, an estimated $62M increase.
- Cubist Systematic Strategies's biggest Q4 2022 reduction was Visa, cutting an estimated $56.8M.
- Cubist Systematic Strategies fully exited Edison International in Q4 2022, selling an estimated $25.2M.
- Cubist Systematic Strategies's ten largest holdings make up 3.1% of its $17.1B portfolio in Q4 2022.
- Cubist Systematic Strategies opened 608 new positions and closed 822 in Q4 2022.
- Cubist Systematic Strategies's portfolio value fell 3.6% quarter-over-quarter to $17.1B.
Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.